Anthony Chan started his research career in 1997 at McMaster University and quickly rose to Full Professorship by 2005. Dr. Chan also obtained a Heart and Stroke Foundation Career Investigator award in 2005, which followed the honour of being recognized with the Canadian Pediatric Society Researc...
Anthony Chan started his research career in 1997 at McMaster University and quickly rose to Full Professorship by 2005. Dr. Chan also obtained a Heart and Stroke Foundation Career Investigator award in 2005, which followed the honour of being recognized with the Canadian Pediatric Society Research Award (2000). Over the last 3 ñ 5 years, Dr. Chan has studied the generation of thrombin leading to a pending patent (PCT WO2007/073597) and development of assays with commercial partners Diagnostica Stago and Technoclone. Dr. Chanís primary research involving a covalent antithrombin-heparin (ATH) complex, that has potential to prevent catheter-related thrombosis in children, has engendered many issued patents that resulted in his recent recognition by McMaster with a distinguished innovator award. In the clinical realm, Dr. Chan is continuing to contribute his expertise in thrombosis by providing around-the-clock free consultation world wide through the 1800NOCLOTS service.